Karan Luthria

Karan Luthria

Auto-generated profile, based on publicly available information

Karan Luthria

Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in Nature
Verified
Journal Article
Open access
PDF file
SSSolomiia Savchuk
Solomiia Savchuk
KGKaylee M. Gentry
Kaylee M. Gentry
WWWengang Wang
Wengang Wang
ECElana Carleton
Elana Carleton
CJCarlos Alberto Oliveira de Biagi Junior
Carlos Alberto Oliveira de Biagi Junior
HVHumsa S. Venkatesh
Humsa S. Venkatesh
Neural activity is increasingly recognized as a crucial regulator of cancer growth. In the brain, neuronal activity robustly influences glioma growth through paracrine mechanisms 1 and by electrochemical integration of malignant cells into neural circuitry via neuron-to-glioma synapses 2,3 . Outside of the central nervous system, innervation of tumours such as prostate, head and neck, breast, pancreatic, and gastrointestinal cancers by peripheral nerves similarly regulates cancer progression 4–12 . However, the extent to which the nervous system regulates small cell lung cancer (SCLC) progression, either in the lung or when growing within the brain, is less well understood. SCLC is a lethal high-grade neuroendocrine tumour that exhibits a strong propensity to metastasize to the brain. Here we demonstrate that in the lung, vagus nerve transection markedly inhibits primary lung tumour development and progression, highlighting a critical role for innervation in SCLC growth. In the brain, SCLC cells co-opt neuronal activity-regulated mechanisms to stimulate growth and progression. Glutamatergic and GABAergic (γ-aminobutyric acid-producing) cortical neuronal activity each drive proliferation of SCLC in the brain through paracrine and synaptic neuron–cancer interactions. SCLC cells form bona fide neuron-to-SCLC synapses and exhibit depolarizing currents with consequent calcium transients in response to neuronal activity; such SCLC cell membrane depolarization is sufficient to promote the growth of intracranial tumours. Together, these findings illustrate that neuronal activity has a crucial role in dictating SCLC pathogenesis.

27 February 2025 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
STSomnath Tagore
Somnath Tagore
LCLindsay Caprio
Lindsay Caprio
AAAmit Dipak Amin
Amit Dipak Amin
KBKresimir Bestak
Kresimir Bestak
KLKaran Luthria
Karan Luthria
BIBenjamin Izar
Benjamin Izar

31 July 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
KLKaran Luthria
Karan Luthria
PSParin Shah
Parin Shah
BCBlake Caldwell
Blake Caldwell
JMJohannes C. Melms
Johannes C. Melms
SASinan Abuzaid
Sinan Abuzaid
BIBenjamin Izar
Benjamin Izar
Purpose: Sarcoma encompasses a diverse group of cancers that are typically resistant to current therapies, including immune checkpoint blockade (ICB), and underlying mechanisms are poorly understood. The contexture of sarcomas limits generation of high-quality data using cutting-edge molecular profiling methods, such as single-cell RNA-sequencing, thus hampering progress in understanding these understudied cancers. Experimental Design: Here, we demonstrate feasibility of producing multimodal single-cell genomics and whole-genome sequencing data from frozen tissues, profiling 75,716 cell transcriptomes of five undifferentiated pleomorphic sarcoma and three intimal sarcoma samples, including paired specimens from two patients treated with ICB. Results: We find that genomic diversity decreases in patients with response to ICB, and, in unbiased analyses, identify cancer cell programs associated with therapy resistance. Although interactions of tumor-infiltrating T lymphocytes within the tumor ecosystem increase in ICB responders, clonal expansion of CD8+ T cells alone was insufficient to predict drug responses. Conclusions: This study provides a framework for studying rare tumors and identifies salient and treatment-associated cancer cell intrinsic and tumor microenvironmental features in sarcomas.

7 January 2025 in MedEdPORTAL
Verified
Journal Article
Open access
KLKaran D. Luthria
Karan D. Luthria
DKDylan K. Kim
Dylan K. Kim
SXSamantha Xing
Samantha Xing
MYMina Yuan
Mina Yuan
JZJerry Zhou
Jerry Zhou
UKUsha S. Krishnan
Usha S. Krishnan
Asian American, Native Hawaiian, and Pacific Islander (AANHPI) people represent one of the largest and most rapidly growing groups in the United States and are often aggregated as a homogeneous, rather than diverse, population in medical research and education. Currently, few educational interventions focus on the disaggregation of AANHPI patient populations and the improvement of knowledge about health disparities that affect AANHPI patients. We developed, implemented, and facilitated a workshop for medical students to address AANHPI health disparities, adaptable for in-person and online formats. The 1-hour session involved a preworkshop evaluation; a PowerPoint presentation outlining the history of the Asian monolith bias, health disparities within AANHPI subgroups, and strategies for health care professionals and trainees to engage effectively with these communities; and a postworkshop evaluation. Pre- and postworkshop evaluations assessed participants' confidence and understanding of AANHPI health disparities. Additionally, the postworkshop evaluation gathered feedback on the presentation. Pre- and postworkshop evaluations revealed that this workshop, attended by 42 diverse participants over two sessions, significantly improved participants' understanding of the Asian monolith bias and AANHPI health care disparities (p < .05). Whether attending virtually or in person, participants reported notable improvements in their self-evaluated confidence in treating AANHPI patients. The AANHPI patient population comprises a myriad of different cultures, historical contexts, and health needs. We present an educational module that is associated with significant improvement of knowledge about health disparities specific to this population, informing further efforts in cultural competence within medical education.

21 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAlexander G. Raufi
Alexander G. Raufi
EDEdridge K. D’SOuza
Edridge K. D’SOuza
MMMichael S. May
Michael S. May
SSSarah Sedycias
Sarah Sedycias
IPIlenia Pellicciotta
Ilenia Pellicciotta
GMGulam A. Manji
Gulam A. Manji
The C-X-C motif chemokine receptor 4 (CXCR4)/C-X-C motif chemokine ligand 12 (CXCL12) axis drives immune exclusion in pancreatic ductal adenocarcinoma (PDA). Building on our preclinical data, we conducted the first stage of an open-label, single-arm phase 2 clinical trial combining CXCR4 inhibition (motixafortide), PD-1 blockade (cemiplimab), and chemotherapy (gemcitabine/nab-paclitaxel [GN]; MCGN) in 11 treatment-naïve patients with metastatic PDA (NCT04543071). The primary endpoint, objective response rate, was 64% partial response and 55% confirmed partial response per Response Evaluation Criteria in Solid Tumors. Secondary endpoints include median progression-free survival of 9.7 months (95% confidence interval [CI]: 5.9-not reached [NR]), overall survival of 10.1 months (95% CI: 9.3-NR), duration of response of 8.2 months, and 91% disease control rate. One patient achieved a pathological complete response after pancreatoduodenectomy and hepatectomy, remaining disease-free for 18 months without adjuvant therapy. Exploratory single-nucleus RNA-sequencing of serial biopsies showed reduced tumor heterogeneity, depletion of epithelial-to-mesenchymal transitional states, and enrichment of CXCL12+ cancer-associated fibroblasts in responders relative to resistant patients. MCGN also induced tumor inflammation as confirmed by tissue staining and T cell rescue. A multicenter randomized phase 2 trial comparing MCGN to GN in patients with treatment-naïve metastatic PDA is ongoing.

3 February 2025 in JMIR Human Factors
Verified
Journal Article
Open access
DNDrashko Nakikj
Drashko Nakikj
DKDavid Kreda
David Kreda
KLKaran Luthria
Karan Luthria
NGNils Gehlenborg
Nils Gehlenborg
Background: Through third party applications, patients in the United States have access to their electronic health record (EHR) data from multiple health care providers. However, these applications offer only a predefined organization of these records by type, time stamp, or provider, leaving out meaningful connections between them. This prevents patients from efficiently reviewing, exploring, and making sense of their EHR data based on current or ongoing health issues. The lack of personalized organization and important connections can limit patients’ ability to use their data and make informed health decisions. Objective: To address these challenges, we created Discovery, an experimental app that enables patients to organize their medical records into collections, analogous to placing pictures in photo albums. These collections are based on the evolving understanding of the patients’ past and ongoing health issues. The app also allows patients to add text notes to collections and their constituent records. By observing how patients used features to select records and assemble them into collections, our goal was to learn about their preferred mechanisms to complete these tasks and the challenges they would face in the wild. We also intended to become more informed about the various ways in which patients could and would like to use collections. Methods: We conducted a think-aloud evaluation study with 14 participants on synthetic data. In session 1, we obtained feedback on the mechanics for creating and assembling collections and adding notes. In session 2, we focused on reviewing collections, finding data patterns within them, and retaining insights, as well as exploring use cases. We conducted reflexive thematic analysis on the transcribed feedback. Results: Collections were useful for personal use (quick access to information, reflection on medical history, tracking health, journaling, and learning from past experiences) and clinical visits (preparation and raising physicians’ awareness). Assembling EHR data into reliable collections could be difficult for typical patients due to considerable manual work and lack of medical knowledge. However, automated collection building could alleviate this issue. Furthermore, having EHR data organized in collections may have limited use. However, augmenting them with patient-generated data, which are entered with flexible richness and structure, could add context, elevate meaning, and improve actionability. Finally, collections might produce a misconstrued health picture, but bringing the physician in the loop for verification could increase their clinical validity. Conclusions: Collections can be a powerful tool for advancing patients’ proactivity, awareness, and self-advocacy, potentially facilitating patient-centered care. However, patients need better support for incorporating their own everyday data and adding meaningful annotations for future reference. Improvements in the comprehensiveness, efficiency, and reliability of the collection assembly process through automation are also necessary.